A recombinant OPG construct was also reported to inhibit bone resorption at the molecular level, which manifested as a decrease in the bone resorption marker urinary N-telopeptide of collagen (NTX) in patients with MM [9]. This evidence concerns the gene TNFRSF11B and Miyoshi myopathy.